---
title: "Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301143410.md"
description: "In Salt Lake City, Carterra® has partnered with AstraZeneca to enhance lab-in-the loop drug discovery. Carterra®, known for its high-throughput surface plasmon resonance platforms, will collaborate with AstraZeneca to create hardware and software solutions. This partnership aims to bolster drug discovery by integrating laboratory systems, software, and data infrastructure with AI-powered workflows. The collaboration signifies a joint effort to advance research in this field."
datetime: "2026-10-07T12:05:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301143410.md)
  - [en](https://longbridge.com/en/news/301143410.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301143410.md)
generator: "portal-rs"
---

# Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration

In Salt Lake City, Carterra® has partnered with AstraZeneca to enhance lab-in-the loop drug discovery. Carterra®, known for its high-throughput surface plasmon resonance platforms, will collaborate with AstraZeneca to create hardware and software solutions. This partnership aims to bolster drug discovery by integrating laboratory systems, software, and data infrastructure with AI-powered workflows. The collaboration signifies a joint effort to advance research in this field.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [AstraZeneca efzimfotase alfa posts 17.05-meter 6MWT gain vs placebo in HICKORY Phase III HPP trial](https://longbridge.com/en/news/301515359.md)
- [FACTBOX-Global healthcare companies invest billions to boost US presence](https://longbridge.com/en/news/301028209.md)
- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [Key facts: AstraZeneca (AZN) NICE OK Enhertu; FDA review; China plan](https://longbridge.com/en/news/299411391.md)
- [AstraZeneca publishes transcript of ERS 2026 investor call and webcast](https://longbridge.com/en/news/298346504.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**